Organization Overview
Alternative names
acetaminophen (tylenol) (2006)
azithromycin (zithromax) (2007)
benzonatate (tessalon) (2015)
carbamazepine (tegretol) (2021)
cefadroxil (duricef) (2017)
celecoxib (celebrex) (2018)
clopidogrel (plavix) (2017)
donepezil (aricept) (2013)
duloxetine (Cymbalta) (2018)
esomeprazole (nexium) (2020)
gabapentin (neurontin) (2005)
levamlodipine (Conjupri) (2019 NDA)
memantine (namenda) (2018)
metformin (glucophage) (2008)
montelukast (singulair) (2017)
omega-3 fatty acids (Omacor) (2020)
paliperidone (invega) (2020)
paroxetine (paxil) (2021)
pramipexole (mirapex) (2018)
pregabalin (lyrica) (2019)
solifenacin (vesicare) (2019)
tramadol (Ultram) (2006)
amphotericin b (fungizone) (2 trials)
asparaginase (elspar) (1 trial)
benzonatate (tessalon) (2 trials)
bevacizumab (avastin) (2 trials)
capecitabine (xeloda) (2 trials)
cyclophosphamide (cytoxan) (3 trials)
desvenlafaxine (pristiq) (1 trial)
docetaxel (taxotere) (11 trials)
doxorubicin (Doxil) (7 trials)
Arterial Occlusive Diseases (Phase 1)
Arteriosclerosis (Phase 2)
Aspergillosis (Phase 2)
Asthma (Phase 1)
Breast Neoplasms (Phase 4)
Candidiasis (Phase 2)
Candidiasis, Invasive (Phase 2)
Carcinoma (Phase 2)
Carcinoma, Hepatocellular (Phase 1)
Carcinoma, Non-Small-Cell Lung (Phase 3)
Cerebral Infarction (Phase 2)
Cough (Phase 3)
Dementia (Phase 3)
Dementia, Vascular (Phase 3)
Depression (Phase 3)
Depressive Disorder (Phase 3)
Depressive Disorder, Major (Phase 3)
Diabetes Mellitus (Phase 3)
Diabetes Mellitus, Type 2 (Phase 3)
Diabetic Neuropathies (Phase 1)
Disease (Phase 3)
Esophageal Squamous Cell Carcinoma (Phase 2)
Hypercalcemia (Phase 2)
Influenza, Human (Phase 2)
Invasive Fungal Infections (Phase 1)
Ischemia (Phase 2)
Leukemia (Phase 3)
Leukemia, Lymphoid (Phase 3)
Leukemia, Myeloid (Phase 2)
Leukemia, Myeloid, Acute (Phase 2)
Lung Neoplasms (Phase 3)
Lymphoma (Phase 4)
Lymphoma, B-Cell (Phase 1)
Lymphoma, Extranodal NK-T-Cell (Phase 2)
Lymphoma, Large B-Cell, Diffuse (Phase 2)
Lymphoma, Non-Hodgkin (Phase 2)
Lymphoma, T-Cell (Phase 2)
Lymphoma, T-Cell, Cutaneous (Phase 2)
Lymphoma, T-Cell, Peripheral (Phase 3)
Mycoses (Phase 1)
Neoplasms (Phase 4)
Neutropenia (Phase 4)
Paraneoplastic Syndromes (Phase 2)
Peripheral Arterial Disease (Phase 2)
Peripheral Nervous System Diseases (Phase 1)
Recurrence (Phase 2)
Rhinitis (Phase 1)
Rhinitis, Allergic (Phase 1)
Schizophrenia (Phase 3)
Small Cell Lung Carcinoma (Phase 2)
Stroke (Phase 2)
Thrombosis (Phase 1)
Thyroid Diseases (Phase 2)
Thyroid Neoplasms (Phase 2)
Triple Negative Breast Neoplasms (Phase 3)
Urinary Bladder Neoplasms (Phase 2)
Venous Thrombosis (Phase 1)